SANGINITA NSE filing

Sanginita Chemicals inks Share Swap, Purchase Agreement for Agastya Green Energy acquisition

The RealCase readHigh impact Positive

Sanginita Chemicals Limited announces a Share Swap and Share Purchase Agreement to acquire Agastya Green Energy Limited (AGEL). This involves issuing 1,52,87,356 shares for AGEL acquisition and 1,91,57,080 shares for cash infusion of ₹13.05 per share. The existing promoters will sell their entire stake, triggering an open offer. The acquisition aims to diversify into the renewable energy sector.

Why it matters

The transaction involves a change in control, acquisition of a new business vertical (renewable energy), and significant share issuances and purchases, indicating a material change in the company's structure and strategic direction.

The market read

The announcement details a strategic acquisition and preferential issue, indicating expansion into a growth sector (renewable energy) and potential for future value creation, which is positive for the company.

Sanginita Chemicals Limited has entered into a Share Swap and Share Purchase Agreement (SSSPA) with Agastya Green Energy Limited (AGEL), B N G Investment LLC (Acquirer 1), and Mr. Anubhav Agarwal (Acquirer 2). The agreement involves the acquisition of AGEL through a share swap with Acquirer 1, in lieu of allotting fresh equity shares of Sanginita Chemicals via a preferential issue. Additionally, Sanginita Chemicals will allot fresh equity shares to Acquirer 1 for cash consideration through a preferential issue. The Acquirers will also purchase the entire stake of the existing promoters and promoter group in Sanginita Chemicals.

Under the SSSPA, Sanginita Chemicals will acquire 95,00,000 equity shares of AGEL from Acquirer 1, in consideration for which it will issue 1,52,87,356 equity shares of face value Rs. 10 each to Acquirer 1 through a preferential allotment at an issue price of Rs. 13.05 per share, aggregating to ₹19,94,99,995.80. Furthermore, Acquirer 1 will infuse cash into Sanginita Chemicals by subscribing to 1,91,57,080 shares at Rs. 13.05 per share through a preferential issue. The existing promoters and promoter group will sell their entire stake of 65,78,994 equity shares in Sanginita Chemicals to the Acquirers.

These transactions trigger an open offer obligation by the Acquirers under SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Upon completion and subject to regulatory compliance, the Acquirers will gain control and become the new promoters of Sanginita Chemicals, while the existing promoters will cease to be part of the promoter group.

The acquisition of AGEL, which is involved in solar panel and cell manufacturing, EPC, and power generation, aligns with Sanginita Chemicals' strategic objective to diversify into future growth-oriented sectors like renewable energy. AGEL, incorporated on March 26, 2025, has no prior turnover as of November 30, 2025. The acquisition is expected to provide Sanginita Chemicals with an integrated platform across the renewable energy value chain and enhance shareholder value. The acquisition is anticipated to be completed within 15 days from the later of the date of approval of a special resolution for the preferential issue or the receipt of necessary approvals from stock exchanges or regulatory authorities.

Filing to action

What to do with a filing like this

Sanginita Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sanginita Chemicals Limited. Read the original for the full detail.

View original filing